232 related articles for article (PubMed ID: 25197934)
1. Sorcin, a calcium binding protein involved in the multidrug resistance mechanisms in cancer cells.
Colotti G; Poser E; Fiorillo A; Genovese I; Chiarini V; Ilari A
Molecules; 2014 Sep; 19(9):13976-89. PubMed ID: 25197934
[TBL] [Abstract][Full Text] [Related]
2. Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis.
Maddalena F; Laudiero G; Piscazzi A; Secondo A; Scorziello A; Lombardi V; Matassa DS; Fersini A; Neri V; Esposito F; Landriscina M
Cancer Res; 2011 Dec; 71(24):7659-69. PubMed ID: 22052463
[TBL] [Abstract][Full Text] [Related]
3. Soluble resistance-related calcium-binding protein in cancers.
Yu X; Mao J; Mahmoud S; Huang H; Zhang Q; Zhang J
Clin Chim Acta; 2018 Nov; 486():369-373. PubMed ID: 30144438
[TBL] [Abstract][Full Text] [Related]
4. Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.
Battista T; Fiorillo A; Chiarini V; Genovese I; Ilari A; Colotti G
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32268494
[TBL] [Abstract][Full Text] [Related]
5. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
Xu P; Jiang YF; Wang JH
Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
[TBL] [Abstract][Full Text] [Related]
6. Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells.
Gao Y; Li W; Liu X; Gao F; Zhao X
Mol Med Rep; 2015 Mar; 11(3):2118-24. PubMed ID: 25394367
[TBL] [Abstract][Full Text] [Related]
7. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
8. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells.
Zhou Y; Xu Y; Tan Y; Qi J; Xiao Y; Yang C; Zhu Z; Xiong D
Leuk Res; 2006 Apr; 30(4):469-76. PubMed ID: 16213583
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.
Hu Y; Cheng X; Li S; Zhou Y; Wang J; Cheng T; Yang M; Xiong D
Cancer Chemother Pharmacol; 2013 Oct; 72(4):789-98. PubMed ID: 24013575
[TBL] [Abstract][Full Text] [Related]
10. Soluble resistance-related calcium-binding protein participates in multiple diseases via protein-protein interactions.
Wang Y; Zhu Y; Pu Z; Li Z; Deng Y; Li N; Peng F
Biochimie; 2021 Oct; 189():76-86. PubMed ID: 34153376
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901].
He QC; Zhang GY; Cao WJ
Ai Zheng; 2008 Apr; 27(4):337-42. PubMed ID: 18423116
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
[TBL] [Abstract][Full Text] [Related]
13. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma.
Liu X; Chen L; Feng B; Liu G
Anat Rec (Hoboken); 2014 Feb; 297(2):215-21. PubMed ID: 24376145
[TBL] [Abstract][Full Text] [Related]
14. The potential mechanism of action of Sorcin and its interacting proteins.
Mao J; Ling F; Gislaine Pires Sanches J; Yu X; Wei Y; Zhang J
Clin Chim Acta; 2020 Nov; 510():741-745. PubMed ID: 32946798
[TBL] [Abstract][Full Text] [Related]
15. [Sorcin overexpression and multidrug resistance in human gastric cancer cells].
Yi H; Yang YX; Tang CE; Chen ZC; Zhang GY; Xiao ZQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):340-4, 349. PubMed ID: 16859119
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp.
He Q; Zhang G; Hou D; Leng A; Xu M; Peng J; Liu T
Oncol Rep; 2011 Jan; 25(1):237-43. PubMed ID: 21109982
[TBL] [Abstract][Full Text] [Related]
17. Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.
Genovese I; Fiorillo A; Ilari A; Masciarelli S; Fazi F; Colotti G
Cell Death Dis; 2017 Jul; 8(7):e2950. PubMed ID: 28726784
[TBL] [Abstract][Full Text] [Related]
18. Structural insight into the binding pattern and interaction mechanism of chemotherapeutic agents with Sorcin by docking and molecular dynamic simulation.
Altharawi A; Ahmad S; Alamri MA; Tahir Ul Qamar M
Colloids Surf B Biointerfaces; 2021 Dec; 208():112098. PubMed ID: 34509085
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of Sorcin-mediated calcium-dependent signal transduction.
Ilari A; Fiorillo A; Poser E; Lalioti VS; Sundell GN; Ivarsson Y; Genovese I; Colotti G
Sci Rep; 2015 Nov; 5():16828. PubMed ID: 26577048
[TBL] [Abstract][Full Text] [Related]
20. Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer.
Zheng BB; Zhang P; Jia WW; Yu LG; Guo XL
J Physiol Biochem; 2012 Jun; 68(2):281-7. PubMed ID: 22701893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
